Overview

Myopia Intervention in Children and Adolescents and Establishment of a Precise Intervention Model

Status:
Recruiting
Trial end date:
2023-08-31
Target enrollment:
Participant gender:
Summary
Investigators are going to conduct a multi-centered randomized clinical trial that myopic children are randomly allocated into three groups: 0.01% atropine, 0.04% atropine and orthokeratology in order to evaluate the efficacy and side effects of different intervention methods and establish a risk factor model to predict the efficacy of myopia intervention, and to provide precise intervention plans and clinical decisions for the control of myopia.
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai Eye Disease Prevention and Treatment Center
Collaborators:
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Treatments:
Atropine
Ophthalmic Solutions